Literature DB >> 10625599

n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation.

C L Curtis1, C E Hughes, C R Flannery, C B Little, J L Harwood, B Caterson.   

Abstract

This study describes specific molecular mechanisms by which supplementation with n-3 fatty acids (i.e. those present in fish oils) can modulate the expression and activity of degradative and inflammatory factors that cause cartilage destruction during arthritis. Our data show that incorporation of n-3 fatty acids (but not other polyunsaturated or saturated fatty acids) into articular cartilage chondrocyte membranes results in a dose-dependent reduction in: (i) the expression and activity of proteoglycan degrading enzymes (aggrecanases) and (ii) the expression of inflammation-inducible cytokines (interleukin (IL)-1alpha and tumor necrosis factor (TNF)-alpha) and cyclooxygenase (COX-2), but not the constitutively expressed cyclooxygenase COX-1. These findings provide evidence that n-3 fatty acid supplementation can specifically affect regulatory mechanisms involved in chondrocyte gene transcription and thus further advocate a beneficial role for dietary fish oil supplementation in alleviation of several of the physiological parameters that cause and propogate arthritic disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10625599     DOI: 10.1074/jbc.275.2.721

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  The influence of Omega3 fatty acids supplementation against aluminum-induced toxicity in male albino rats.

Authors:  Samah S Oda
Journal:  Environ Sci Pollut Res Int       Date:  2016-04-08       Impact factor: 4.223

2.  Cloning and molecular characterization of delta12-fatty acid desaturase gene from Mortierella isabellina.

Authors:  Ming-Chun Li; Hang Li; Dong-Sheng Wei; Lai-Jun Xing
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 3.  Nonsurgical Management of Cartilage Defects of the Knee: Who, When, Why, and How?

Authors:  Chad Hanaoka; Cameron Fausett; Prakash Jayabalan
Journal:  J Knee Surg       Date:  2020-07-14       Impact factor: 2.757

4.  Deficiency of G-protein coupled receptor 40, a lipid-activated receptor, heightens in vitro- and in vivo-induced murine osteoarthritis.

Authors:  Laurent-Emmanuel Monfoulet; Claire Philippe; Sylvie Mercier; Véronique Coxam; Yohann Wittrant
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-13

5.  Cordycepin modulates inflammatory and catabolic gene expression in interleukin-1beta-induced human chondrocytes from advanced-stage osteoarthritis: an in vitro study.

Authors:  Pengfei Hu; Weiping Chen; Jiapeng Bao; Lifeng Jiang; Lidong Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 6.  Pathogenesis of degenerative temporomandibular joint arthritides.

Authors:  Stephen B Milam
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

7.  Effects of hexosamines and omega-3/omega-6 fatty acids on pH regulation by interleukin 1-treated isolated bovine articular chondrocytes.

Authors:  Amanda L Tattersall; Robert J Wilkins
Journal:  Pflugers Arch       Date:  2008-01-17       Impact factor: 3.657

8.  Effect of dietary fatty acids on inflammatory gene expression in healthy humans.

Authors:  Kelly L Weaver; Priscilla Ivester; Michael Seeds; L Douglas Case; Jonathan P Arm; Floyd H Chilton
Journal:  J Biol Chem       Date:  2009-04-09       Impact factor: 5.157

9.  Decreased production of inflammatory mediators in human osteoarthritic chondrocytes by conjugated linoleic acids.

Authors:  Chwan-Li Shen; Dale M Dunn; Jack H Henry; Yong Li; Bruce A Watkins
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

Review 10.  Immune regulation and anti-cancer activity by lipid inflammatory mediators.

Authors:  Saraswoti Khadge; John Graham Sharp; Timothy R McGuire; Geoffrey M Thiele; Paul Black; Concetta DiRusso; Leah Cook; Lynell W Klassen; James E Talmadge
Journal:  Int Immunopharmacol       Date:  2018-11-14       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.